Eton Pharma Chief Business Officer David Krempa reports disposal of 25,000 common shares valued at $1.63 million

Reuters2026/08/24 21:20

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Eton Pharmaceuticals Chief Business Officer David Krempa sold 25,000 common shares on Aug. 24, 2026 at USD 65.07.
Sale followed the exercise of 25,000 employee stock options at USD 7.31 on the same day.
Directly owned common shares fell to 37,025 after the transactions.
Employee stock options held increased to 70,000 following the exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-028846), on August 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Eton Pharma Chief Business Officer David Krempa reports disposal of 25,000 common shares valued at $1.63 million

You may also like

Crypto prices